SARA B CAPITELLI
CIK 1509032 · VP Fin & Principal Account Off · last filed 2018-07-13
SARA B CAPITELLI is a VP Fin & Principal Account Off who has filed 10 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for CASI, was dated Jul 13, 2018.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
10
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals, Inc. (CASI) Delisted | VP Fin & Principal Account Off | 35,000 | $0.28 | $9.8K | $0 | 7 | 2018-07-13 |
| CASI Pharmaceuticals, Inc. (ENMD) Delisted | VP, Finance & PAO | — | — | — | $0 | 3 | 2013-05-31 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-07-13 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Mixed | — | -$192.7K | EDGAR |
| 2018-04-13 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Mixed | — | -$154.9K | EDGAR |
| 2017-10-03 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-04 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-08 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-14 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-31 | CASI Pharmaceuticals, Inc. (ENMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-08-17 | CASI Pharmaceuticals, Inc. (ENMD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-12 | CASI Pharmaceuticals, Inc. (ENMD) Delisted | Grant (A) | — | $0 | EDGAR |